Kurt S. Bantilan

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Meghan C. Thompson, Rosemary Harrup, Catherine C. Coombs et al. · Blood Advances · 2022 · 57 citations · Full text

Medicine, Hematology, Oncology +13

Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma

Neha Mehta–Shah, Kimiteru Ito, Kurt S. Bantilan et al. · Blood Advances · 2019 · 52 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

Gunjan L. Shah, Joachim Yahalom, Matthew J. Matasar et al. · British Journal of Haematology · 2016 · 30 citations · Full text

Medicine, Clinical Sciences, Oncology +16

Prognostic Value of¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Laure Michaud, Kurt S. Bantilan, Audrey Mauguen et al. · Journal of Nuclear Medicine · 2022 · 27 citations · Full text

Medicine, Oncology, Chemotherapy +15

Inspired by Sharks: A Biomimetic Skeleton for the Flapping, Propulsive Tail of an Aquatic Robot

John H. Long, Tom Koob, J. J. Schaefer et al. · Marine Technology Society Journal · 2011 · 23 citations · Full text

Life Sciences, Anatomy, Zoology +16